https://www.linkedin.com/in/minhong-jang-a031b229/?originalSubdomain=kr 백승욱 의장님 mission: conquer cancer through ai - cancer diagnosis support solutions (insight), cancer treatment support solution (scope) 진단과 치료로 생존률을 높인다 - 면역항암제의 (immune cell distribution immunca) 위대한 회사는 아니다 (앞선 연사와 연관) ⭐️right team, right direction ## team 6 engineer in kaist - who do we want? caegory (lunit's core culture) a team of smart team players, united by a passion for growth and a global mindset to tackle big, meaningful challenges - learning unit = lunit domain expertise is something that can be learned or built over time - esp. in early stage however, we were missing a piece in globalize - medical research - clinical env understang - global business dev -> hire brandon suh (), 2019 대표로 서범석 ![[Pasted image 20250405202954.png|100]] Q1: what's next breakthrough tech that'll change the world - image -> 2012 imagenet (supervision; jeffrey hinton, acquired by google), - dnn Q2: what's biggest problem? - dress recognition, description, shopping (similar result) - user test - technology keeps growing, where's the market impact our product should solve important problem bettern than human, we should have upside potential, field where we have confidence to excel -> medicine (not fashion) art of medicine, evidence based medicine, data-driven medicine pain point: mammograph 30% is missed (), 조직검사는 4명 중 1명 의견 다름 how to build a great company -> 😂not great company Q. 정치, recipe of collab - not equal equity, similar salary, 결국 lunit잘되기 위해 싸우는거다, 승욱을 미워하긴했지만 싫어하진 않았다 (개인 이익 취한적은 없었다) 친구와 창업 / 개인사, 오랫동안. 비즈니스하다가 깨져도 새로운 기술로 물건 (원래하던걸 더 잘하든, 싸게 ), data acquisition, sales (subscription방식) pricing -> 의사의 2,30% (reading할때마다 fee)가 upper limit - two market 직접 의사 (50%) vs medical device company (50%) - out of pocket , 정부 허가 노력함 (현재는 비급여로), 일본과 같이함 - 최신동향 - path ai (boston - europen; clinical trila data analysis 승인남), ai + therapeutic